Avance Biosciences is excited to announce its participation in the upcoming Immunogenicity & Bioassay Summit, taking place from October 15 -18, 2024, in Washington DC. This is the #1 Immunogenicity & Bioassay Event in the U.S.
At Avance Biosciences, we provide a suite of services tailored to meet the diverse needs of our clients in immunogenicity testing. Our offerings include:
- Immunogenicity Assessments: We utilize advanced assays to evaluate the immunogenic potential of therapeutic proteins, ensuring compliance with regulatory guidelines.
- ELISA, MSD, and Flow Cytometry Services: Our highly sensitive and specific assays facilitate the detection of anti-drug antibodies (ADAs) and immune responses, providing valuable insights into product safety and efficacy.
- PK/PD Studies: We integrate pharmacokinetics and pharmacodynamics into our testing protocols to provide a comprehensive understanding of drug behavior and immune response.
- Customized Solutions: Understanding that each project is unique, we offer tailored approaches to meet the specific requirements of our clients, ensuring accurate and reliable results.
“We are excited to participate in the Immunogenicity & Bioassay Summit, where we can connect with industry leaders and showcase our innovative solutions in immunogenicity testing. Our team is dedicated to providing comprehensive support for the development of safe and effective biologics, and we look forward to engaging with attendees to explore how we can collaborate to drive success in this critical area.”
Cal Froberg – Senior VP of Sales & Marketing at Avance Biosciences.
We look forward to engaging with fellow researchers, scientists, and industry experts at this exciting event!
When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!
